Braving new worlds: To conquer, to endure

Physical Therapy

Volumn 84, Issue 11, 2004, Pages 1056-1086

  Moffat, Marilyn ^a,b,c,d  

^a APTA's House of Delegates   (United States)

^b APTA   (United States)

^c Task Force Intl Definition Phys T   (United States)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN; FIBRINOLYTIC AGENT; GLUCOSAMINE; INSULIN; LIPOPROTEIN; STATIN; TISSUE PLASMINOGEN ACTIVATOR;

BIODEGRADABLE IMPLANT; BONE REGENERATION; CEREBRAL PALSY; CHONDROPATHY; COMPUTER AIDED DESIGN; CONFERENCE PAPER; DIABETES MELLITUS; FRACTURE; GAIT; GENE MAPPING; GENE THERAPY; HEART DISEASE; HUMAN; KNEE MENISCUS RUPTURE; LIMB AMPUTATION; LUNG DISEASE; MEDICAL GENETICS; MEDICAL TECHNOLOGY; MOVEMENT THERAPY; MULTIPLE SCLEROSIS; MUSCULAR DYSTROPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; OSTEOPOROSIS; PARKINSON DISEASE; PHYSIOTHERAPY; PROSTHESIS; ROBOTICS; SPINAL CORD INJURY; STEM CELL GENE THERAPY; STROKE; TENDON INJURY; VASCULAR DISEASE; VIRTUAL REALITY; WHEELCHAIR; ARTICLE; CARDIOVASCULAR DISEASE; FIBRINOLYTIC THERAPY; KINESIOTHERAPY; LIMB PROSTHESIS; MUSCULOSKELETAL DISEASE; ORTHOTICS; PATHOPHYSIOLOGY; PROSTHESES AND ORTHOSES; TISSUE ENGINEERING;

ARTIFICIAL LIMBS; CARDIOVASCULAR DISEASES; CEREBRAL PALSY; EXERCISE THERAPY; FRACTURES, BONE; HUMANS; MUSCULOSKELETAL DISEASES; ORTHOTIC DEVICES; PARKINSON DISEASE; PHYSICAL THERAPY MODALITIES; PROSTHESES AND IMPLANTS; THROMBOLYTIC THERAPY; TISSUE ENGINEERING;

EID: 7544241631     PISSN: 00319023     EISSN: None     Source Type: Journal    
DOI: 10.1093/ptj/84.11.1056     Document Type: Conference Paper

References (158)

1. Girolami B, Bernardi E, Prins MH, et al. Antiplatelet therapy and other interventions after revascularization procedures in patients with peripheral arterial disease; a meta analysis. Eur J Vasc Surg. 2000;19: 370-380.
2. Fava M, Loyola S, Huete I. Massive pulmonary embolism: treatment with the hydrolyser thrombectomy catheter. J Vasc Interv Radiol. 2000; 11:1159-1164.
3. Reckers JA, Baarslag HJ, Koolen MG, et al. Mechanical thrombetctomy for early treatment of massive pulmonary embolism. Cardiovasc Interv Radiol. 2003;26:246-250.
4. Kaudewitz P, Klovekorn W, Rother W. Treatment of leg vein telangiectases: 1-year results with a new 940 nm diode laser. Dermatol Surg. 2002;28:1031-1024.
5. Weiss RA. Radiofrequency-mediated endovenous occlusion. In: Weiss RA, Feied CF, Weiss MA, eds. Vein Diagnosis and Treatment: A Comprehensive Approach. New York, NY: McGraw-Hill Inc; 2001:211-221
6. Zotto LM. Treating varicose veins with transilluminated powered phlebectomy. AORN J. 2002;76:980-994.
7. Bergan J, Kumin N, Owens E, Sparks S. Surgical and endovascular treatment of lower extremity venous insufficiency. J Vasc Interv Radiol. 2002;13:563-568.
8. Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA. 2003;290: 2292-2300.
9. Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA. 2004; 291:1071-1080.
10. Shishehbor MH, Bhatt DL, Topol EJ. Using C-reactive protein to assess cardiovascular disease risk. Clev Clin J Med. 2003;70:634-640.
11. Caslake MJ, Packard CJ. Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease. Curr Opin Lipidol. 2003;14:347-352.
12. Braly J, Holford P. The H Factor Solution: Homocysteine, the Best Single Indicator of Whether You Are Likely to Live Long or Die Young. North Bergen NJ: Basic Health Publications Inc; 2003.
13. Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA. 2003;290: 932-940.
14. Craig WY, Neveux LM, Palomaki GE, et al. Lipoprotein(a) as a risk factor for ischemic heart disease: meta-analysis of prospective studies. Clin Chem. 1998;44:2301-2306.
15. Robot assisted surgery. Cleveland Clinic Heart Center Web site. Available at: http://www.clevelandclinic.org/heartcenter/pub/history/future/robotics.asp. Accessed January 13, 2004.
16. A phase I, open-label, non-randomized, dose escalation, multi center study to assess the safety and cardiovascular effects of autologous skeletal myoblast (MyoCell™) implantation by a transendocardial catheter delivery system (MyoCath™) in congestive heart failure patients post myocardial infarction (s) with previous placement of an implantable cardioverter defibrillator (ICD). Available at: http://www.clinicaltrials.gov/ct/gui/show/ NCT00054678?order=14. Accessed January 15, 2004.
17. Patel AN, Vina RF, Geffner, L, et al. Surgical treatment for congestive heart failure using autologous adult stem cell transplantation: a prospective randomized study. Paper presented at: 84th Annual Meeting of the American Association for Thoracic Surgery; Toronto, Ontario, Canada; April 25, 2004.
18. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002;106:1913-1918.
19. Strauer BE, Brehm M, Zeus T, et al. Mending the broken heart: resident and non-resident primitive cells. Paper presented at: AHA Scientific Session; November 10, 2003; Orlando, Fla.
20. Stewart D, Deng YZ, Zhang Q, et al. Stem cells in the treatment of pulmonary arterial hypertension in rats. Paper presented at: AHA Scientific Session; November 10, 2003; Orlando, Fla.
21. Kunz G, Liang G, Cuculoski F, et al. Progenitor Cells Predict Heart Disease Severity. New Orleans, La: American College of Cardiology; March 9, 2004.
22. Suratt B, Cool CD, Serls AE, et al. Human pulmonary chimerism after hematopoietic stem cell transplantation. Am J Resp Crit Care Med. 2003;16:318-322.
23. Gene therapy: the future of cystic fibrosis treatment? Available at: http://www.healthnewsflash.com/conditions/cystic_fibrosis.htm#therapy. Accessed May 12, 2004.
24. Gene studies: AAV-CFTR gene transfer agent. Available at: http://www.cff.org/research/genetic_studies_aavcftr_gene_transfer_ agent.cfm. Accessed May 12, 2004.
25. Gene therapies: CF gene therapy trial using compacted DNA? Available at: http://www.cff.org/research/gene_therapy_compacted_ DNA.cfm. Accessed May 12, 2004.
26. Albers GW, Bates VE, Clark WM, et al. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA. 2000;283:1189-1191.
27. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324: 71-86.
28. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study - a randomized controlled trial. JAMA. 1999;282:2003-2011.
29. Straus SE, Majumdar SR, McAlister FA. New evidence for stroke prevention: scientific review. JAMA. 2002;288:1388-1395.
30. US Multicenter, Randomized Controlled Study Comparing the Performance of Onyx (EVOH) and TRUFILL (n-BCA) in the Presurgical Embolization of Brain Artenovenous Malformations (BAVMs). Washington, DC: Georgetown University Hospital; 2003.
31. Takeda H, Spatz M, Ruetzler C, et al. Induction of mucosal tolerance to E-selectin prevents ischemic and hemorrhagic stroke in spontaneously hypertensive genetically stroke-prone rats. Stroke. 2002; 33:2156-2164.
32. Burgar CG, Lum PS, Shor PC, Machiel-VanderLoos HS. Development of robots for rehabilitation therapy: the Palo Alto VA/Stanford experience. J Rehabil Res Dev. 2000;37:663-673.
33. Krebs HB, Volpe BT, Aisena ML, Hogan N. Increasing productivity and quality of care: robot-aided neuro-rehabilitation. J Rehabil Res Dev. 2000;37:639-652.
34. Lum PS, Burgar CG, Shor PC, et al. Robot-assisted movement training compared with conventional therapy techniques for the rehabilitation of upper-limb motor function after stroke. Arch Phys Med Rehabil 2002;83:952-959.
35. Volpe BT, Ferraro M, Krebs HI, Hogan N. Robotics in the rehabilitation treatment of patients with stroke. Curr Atheroscler Rep. 2002;4: 270-276.
36. Hesse S, Werner C, Uhlenbrock D, et al. An electromechanical gait trainer for restoration of gait in hemiparetic stroke patients: preliminary results. Neurorehabil Neural Repair. 2001;15:39-50.
37. Hidler J, Hornby G. Gait restoration in hemiparetic stroke patients using goal-directed, robotic-assisted treadmill training. Clinical trial at National Rehabilitation Hospital, 2003. Available at: http://anbl.cua. edu/Clinical.cfm. Accessed March 1, 2004.
38. Taub E, Wolf S. Constraint induced movement techniques to facilitate upper extremity use in stroke patients. Topics in Stroke Rehabilitation. 1997;3(4):38-61.
39. Kunkel AB, Kopp B, Muller G, et al. Constraint-induced movement therapy for motor recovery in chronic stroke patients. Arch Phys Med Rehabil. 1999;80:624-628.
40. Levy CE, Nichols DS, Schmalbrock PM, et al. Functional MRI evidence of cortical reorganization in upper-limb stroke hemiplegia treated with constraint-induced movement therapy. Am J Phys Med Rehabil. 2001;80:4-12.
41. Schaechter JD, Kraft E, Hilliard TS, et al. Motor recovery and cortical reorganization after constraint-induced movement therapy in stroke patients: a preliminary study. Neurorehabil Neural Repair. 2002;16:326-328.
42. National Institute of Neurological Disorders and Stroke clinical research study. Improvements of hand function in chronic stroke related to upper arm anesthesia. Available at: http://www.clinicaltrials.gov/ct/show/NCT00006414? order=11. Accessed April 26, 2004.
43. National Institute of Neurological Disorders and Stroke clinical research study. Motor recovery in recent stroke patients treated with amphetamine and physical therapy. Available at: http://www. clinicaltrials.gov/ct/gui/c/alb/ show/NCT00001783. Accessed April 26, 2004.
44. National Institute of Neurological Disorders and Stroke clinical research study. Repetitive transcranial magnetic stimulation in chronic stroke patients: dose effect on motor cortex excitability, motor performance, and safety using different stimulation parameters. Available at: http://clinicalstudies.info.nih. gov/cgi/detail.cgi?A_03-N-0049.html. Accessed April 26, 2004.
45. National Institute of Neurological Disorders and Stroke clinical research study. Improvement of motor learning in chronic stroke patients by transcranial dc stimulation. Available at: http://clinicalstudies.info.nih.gov/cgi/detail. cgi?A_03-N-0267.html. Accessed April 26, 2004.
46. Path G, Seufert J. Current status and perspectives of stem cell therapy for the treatment of diabetes mellitus. Med Klin. 2003;98: 277-282.
47. Chronic rheumatic conditions. World Health Organization Web site. Available at: http://www.who.int/ncd/cral. Accessed April 9, 2004.
48. Marks LJ, Michael JW. Science, medicine, and the future: artificial limbs. BMJ. 2001;323:732-735.
49. Inside Smithsonian Research. Washington, DC: Smithsonian Office of Public Affairs; Spring 2004.
50. C-Leg® System. Otto Bock HealthCare Web site. Available at: http://www.ottobockus.com/products/lower_limb_prosthetics/c-leg. asp. Accessed March 4, 2004.
51. Sandia National Laboratories news release: agreement signed to create "smart" leg. Available at: http://www.sandia.gov/media/NewsRel/NR2000/ smartleg.htm. Accessed November 12, 2003.
52. Smart Integrated Lower Limb (SILL). Available at: http://www. sandia.gov/isrc/SILL.html. Accessed December 12, 2003
53. Ferguson S, Dunlop GR. Grasp recognition from myoelectric signals. Paper presented at: Proceedings of the 2002 Australasian Conference on Robotics and Automation; November 27-29, 2002; Auckland, New Zealand.
54. Carrozza MC, Vecchi F, Sebastiani F, et al. Experimental analysis of an innovative prosthetic hand with proprioceptive sensors. Paper presented at: IEEE International Conference on Robotics and Automation ICRA; September 14-19, 2003; Taipei, Taiwan.
55. Carrozza MC, Suppo C, Sebastiani F, et al. The spring hand: development of a self-adaptive prosthesis for restoring natural grasping. Auton Robots. 2004:16;125-141.
56. Integrum Web site. Available at: http://www.integrum.se and http://www.alfred.org.au/departments/plastic_and_reconstructive_ surgery_unit.html. Accessed January 15, 2004.
57. Brånemark R, Brånemark P-I, Rydevik B, Myers RR. Osseointegration in skeletal reconstruction and rehabilitation. J Rehabil Res Dev. 2001;38:175-181. Also available at http://www.alfred.org.au/departments/ plastic_and_reconstructive_surgery_unit.html.
58. Mark LJ, Michael JW. Science, medicine, and the future. BMJ. 2001;323:732-735.
59. Alvarado AS. Regeneration in the metazoans: why does it happen? BioEssays. 2000;22:578-590.
60. Smith WR, Caton LA, Ziran BH, et al. Efficacy of composite allograft and demineralized bone matrix in the treatment of high-energy tibial plateau fractures with extensive bone loss. Poster presentation at: Orthopaedic Trauma Association Annual Meeting; October 22-24, 2000; Charlotte, NC.
61. USCEment: synthesis of reactive calcium phosphate nanoparticles and their use in making biomimetric biomaterials for bone repair. Available at: http://ip.research.sc.edu/catalog/00262.htm. Accessed May 26, 2004.
62. Vertebroplasty treatments. Society of Interventional Radiology Web site. Available at: http://www.sirweb.org/patPub/vertebroplasty Treatments.shtml. Accessed December 9, 2003.
63. Peterson L, Brittberg M, Kiviranta I, et al. Autologous chondrocyte transplantation: biomechanics and long-term durability. Am J Sports Med. 2002;30:2-12.
64. Kelly EB. Tissue implants: conquering the impossible. Available at: http://www.orthopedictechreview.com/issues/julaug01/pg32.htm. Accessed May 26, 2004.
65. Spiro RC, Nokelainen M, Yang C, et al. Recombinant human collagens for bone and cartilage repair. Euro Cells Materials. 2002; 4(suppl 1):16.
66. Homegrown ligaments could repair debilitating knee injuries. Tufts Journal (serial online). Available at: Available at: http://tuftsjournal.tufts. edu/archive/2002/march/briefs/ligament.shtml. Accessed May 26, 2004.
67. Bobic V. Tissue repair techniques of the future: options for articular cartilage injury. Report presented at: Techvest, LLC First Annual Conference on Tissue Repair, Replacement and Regeneration; October 27-28, 1999; New York, NY.
68. Available at: http://www.medscape.com/viewarticle/405599. Accessed March 4, 2004.
69. Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem. 1994;56:283-294.
70. Johnstone B. Mesenchymal stem cells and chondrogenesis. Euro Cells Materials. 2002;4(suppl 1):27.
71. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999;5:309-313.
72. Total disc replacement: ProDisc. Available at: http://www.spine-health. com/research/discupdate/artificial/artificial04.html. Accessed May 31, 2004.
73. Johnsson R, Strōmquist B, Aspenberg P. Randomised radiostereometric study comparing osteogenic protein-1 (BMP-7) and autograft bone in human noninstrumented posterolateral lumbar fusion. Spine. 2002;27:2654-2661.
74. Degenerative disc disease. Available at: http://www.spinesource. com/Back-Pain-Disorders/disc-degeneration.html. Accessed May 31, 2004.
75. Bruns J, Kahrs J, Kampen J, et al. Autologous perichondral tissue for meniscal replacement. J Bone Joint Surg Br. 1998;80:918-923.
76. Knutsen G, Engebretsen L, Ludvigen T, et al. Autologous chondrocyte implantation compared with microfracture in the knee: a randomized clinical trial. J Bone Joint Surg Am. 2004;86:455-464.
77. Evans CH, Gouze JN, Gouze E, et al. Osteoarthritis gene therapy. Gene Ther. 2004;11:379-389.
78. Reginster JY, Deroisy R, Paul I, et al. Glucosamine sulfate significantly reduces progression of knee osteoarthritis over 3 years: a large, randomized, placebo-controlled, double-blind, prospective trial. Paper presented at: American College of Rheumatology Annual Meeting. November 17, 1999; Boston, Mass.
79. Richy F, Bruyere O, Ethgen O, et al. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med. 2003;163:1514-1522.
80. Glucosamine/Condroitin Arthritis Intervention Trial (GAIT) begins patient recruitment. Available at: http://nccam.nih.gov/news/19972000/121100/. Accessed June 5, 2004.
81. Gentis obtains rights for skin to cartilage transformation technology. Available at: http://www.gentisinc.com/News1.htm. Accessed May 31, 2004.
82. Simmers A. Catch and release. Natural History. 2003;11:36-37.
83. Donahue SW, Vaughan MR, Demers LM, Donahue HJ. Bone formation is not impaired by hibernation (disuse) in black bears Ursus americanus. J Exp Biol. 2003;206:4233-4239.
84. Skillington J, Choy L, Derynck R. Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes. J Cell Biol. 2002;159:135-146.
85. Shea LD, Smiley E, Bonadio J, Mooney DJ. DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol. 1999;17: 551-554.
86. Gasser JA. Stem cells in the treatment of osteoporosis. Eur Cells Materials. 2003;6(suppl 2):21.
87. Cellular Replacement Therapy™ (CRT). Available at: http://www.primegenbiotech.com/technology.php. Accessed June 1, 2004.
88. Chabas D, Baranzini SE, Mitchell D, et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science. 2001;294(5547):1731-1735.
89. Steinman L. Engineering better cytokines. Nat Biotechnol. 2003;2I:1293.
90. Steinman L, Heller R. An array of possibilities for multiple sclerosis. Nat Med. 2002;8:451-453.
91. Vollmer T. Cholesterol-lowering drug effective in treating most common form of MS. Scientific presentation at: American Academy of Neurology Annual Meeting; April 1, 2003; Honolulu, Hi.
92. + exchanger. Proc Natl Acad Sci U S A. 2004;101:8168-8173.
93. Carreras E, Saiz A, Marin P, et al. CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients. Haematologica. 2003;88:306-314.
94. Iezzi S, Cossu G, Nervi C, et al. Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases. Proc Natl Acad Sci U S A. 2002;99:7757-7762.
95. Recent research developments supported by the Muscular Dystrophy Association. Available at: http://www.mdausa.org/publications/resdev.html. Accessed June 1, 2004.
96. Gussoni E, Soneoka Y, Strickland CD, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 1999;401:390-394.
97. Sampaolesi M, Torrente Y, Innocenzi A, et al. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science. 2003;301(5632):487-492.
98. Brain banking for neurodegenerative disease. Curr Opin Neurolobiol. 2003;4:459-463.
99. Dekker MC, van Swieten JC, Houwing-Duistermaat JJ, et al. A clinical-genetic study of Parkinson's disease in a genetically isolated community. J Neurol. 2003;250:1056-1062.
100. Pankratz N, Nichols WC, Uniacke SK, et al. Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families. Hum Mol Genet. 2003;12:2599-2608.
101. Benabid AL. Deep brain stimulation for Parkinson's disease . Curr Opin Neurobiol. 2003;13:696-706.
102. Gill SS, Patel NK, Hotton GR, et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med. 2003;9:589-595.
103. Anderson A. Research offers hope to patients with Parkinson's disease. Available at: http://www.fromthelab.net/vol01/is2/02oct_n3. htm. Accessed June 9, 2004.
104. Henkel J. Parkinson's disease: new treatments slow onslaught of symptoms. Available at: http://www.fda.gov/fdac/features/1998/498_pd.html. Accessed January 17, 2004.
105. Neuroscience clinic. Available at: http://www.pallidotomy.com/ tissue_and_cell_.html. Accessed January 17, 2004.
106. Treatments for Parkinson's disease. Available at: http://www. holistic-online.com/Remedies/Parkinson/pd_treatments.htm. Accessed January 17, 2004.
107. Kim JH, Auerbach JM, Rodriguez-Gomez JA, et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature. 2002;418(6893):50-66.
108. Bjorklund A, Dunnett SB, Brundin P, et al. Neural transplantation for the treatment of Parkinson's disease. Lancet Neurol. 2003;2: 437-445.
109. Isacson O, Bjorklund LM, Schumacher JM. Towards full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells. Ann Neurol. 2003;53(suppl 3):S135-S146.
110. Jiang Y, Balkrishna NJ, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult bone marrow. Nature. 2002; 418(6893):41-49.
111. Hill WD, Hess DC, Martin-Studdard A, et al. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J Neuropathol Exp Neurol. 2004;63:84-96.
112. Bartley J, Carroll JE. Stem cell therapy for cerebral palsy. Expert Opin Biol Ther. 2003;3:541-549.
113. Cerebral palsy: hope through research. National Institute for Neurological Disorders and Stroke Web site. Available at: http://www.ninds.nih. gov/health_and_medical/pubs/cerebral_palsyhtr.htm# What%20Specific%20Treatments. Accessed June 3, 2004.
114. The treatment of cerebral palsy. United Cerebral Palsy Web site. Available at: http://www.ucp.org/ucp_generaldoc.cfm/1/4/11654/11654-11654/4790. Accessed June 5, 2004.
115. Advanced Orthotic Designs Inc Web site. Available at: http://www.aodmobility.com/Contact_Us/Profile/body_profile.htm. Accessed April 9, 2004.
116. Taub E, Ramey SL, DeLuca S, Echols K. Efficacy of constraint-induced movement therapy for children with cerebral palsy with asymmetric motor impairment. Pediatrics. 2004;113:305-312.
117. Teng YD, Lavik EB, Qu X, et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A. 2002;99:3024-3029.
118. Areas of practice: lifelong knee/ankle/foot care - major technological advances in knee-ankle-foot (KAFO's) orthoses. SCOPe Orthotics & Prosthetics Inc Web site. Available at: http://www.scop.net/areas_kneeAnkleFoot.htm. Accessed April 14, 2004.
119. Agarwal S, Triolo RJ, Kobetic R, et al. Long-term user perceptions of an implanted neuroprosthesis for exercise, standing, and transfers after spinal cord injury. J Rehabil Res Dev. 2003;40:241-252.
120. Taylor P, Esnouf J, Hobby J. Pattern of use and user satisfaction of Neuro Control Freehand system. Spinal Cord. 2001;39:156-160.
121. Johnson D, Whitworth H. Recent developments in plastic surgery. BMJ. 2002;325:319-322.
122. Taylor P, Esnouf J, Hobby J. The functional impact of the Freehand System on tetraplegic hand function: clinical results. Spinal Cord. 2002;40:560-566.
123. Memberg WD, Crago PE, Keith MW. Restoration of elbow extension via functional electrical stimulation in individuals with tetraplegia. J Rehabil Res Dev. 2003;40:477-486.
124. Lauer RT, Peckham PH, Kilgore KL. EEC-based control of a hand grasp neuroprosthesis. Neurol Rep. 1999;10:1-5.
125. Lauer RT, Peckham PH, Kilgore KL, Heetderks WJ. Applications of cortical signals to neuroprosthetic control: a critical review. IEEE Trans Rehabil Eng. 2000;8:205-207.
126. Mojarradi M, Binkley D, Blalock B, et al. A miniaturized neuroprothesis suitable for implantation into the brain. IEEE Trans Neural Sys Rehabil Eng. 2003;1:38-42.
127. Nicolelis MA, Dimitrov D, Carmena JM, et al. Chronic, multisite, multielectrode recordings in macaque monkeys. Proc Natl Acad Sci U S A. 2003;100:11041-11046.
128. Carmena JM, Lebedev MA, Crist RE, et al. Learning to control a brain-machine interface for reaching and grasping by primates. Public Library Sci Bio. 2003;1:193-208.
129. Robomedica Inc Web site. Available at: http://www.robomedica. com/projects.htm. Accessed April 7, 2004.
130. Yobotics Inc Web-site. Available at: http://www.yobotics.com. Accessed April 7, 2004.
131. Hunter D. Exoskeleton soon available for the elderly. Available at: http://www.betterhumans.com/Errors/index.aspx?aspxerrorpath=/ Exoskeleton_Soon_Available_for_the_Elderly.Article.2003-08-22-1.aspx. Accessed April 8, 2004.
132. The ClinSeat™ System. Tekscan Web site. Available at: http://www.tekscan.com/medical/system_clinseat.html. Accessed December 10, 2003.
133. Fehr L, Langbein WE, Skaar SB. Adequacy of power wheelchair control interfaces for persons with severe disabilities: a clinical survey. J Rehabil Res Dev. 2000;37:353-360.
134. Del Castillo G, Skaar SB, Fehr L. Extending teach and repeat to pivoting wheelchairs. J Systemics Cybernetics Informatics. Publication pending. Available at: http://www.iiisci.org/Journal/SCI/Browser.asp?var. Accessed April 12, 2004.
135. Del Castillo G, Skaar SB, Cárdenas JA, Fehr L. An approach to sonar obstacle detection in an autonomous vision-based mobile robot. Preliminary version of report. Available at: http://www.nd.edu/~gdelcast/Docs.htm. Accessed April 12, 2004.
136. A wheelchair that climbs and a new set of eyes. Available at: http://www.ergoweb.com/news/detail.cfm?id=633. Accessed May 20, 2004.
137. Human Genome Program. Genomics and Its Impact on Science and Society: A 2003 Primer. Washington, DC, US Department of Energy; 2003.
138. Ariel Performance Analysis System. Ariel Dynamics Inc Web site. Available at: http://www.sportsci.com/adi2001/adi/products/apas/ system/description.asp. Accessed January 20, 2004.
139. Gait video tape. Available at: http://www.vicon.com/main/technology/img/ ws%20movie%20video.jpg. Accessed January 20, 2004.
140. Xtreme Sports Snowboard Simulator. Available at: http://www. vrealities.com/xtreme.html. Accessed January 30, 2004.
141. Gait analysis. Vicon Motion Systems Web site. Available at: http://www.vicon.com/main/applications/gait_analysis.shtml. Accessed December 11, 2003.
142. Medical pressure measurement overview. Tekscan Web site. Available at: http://www.tekscan.com/medical/specs_mobile.html. Accessed January 12, 2004.
143. 5DT Datagloves. Meta Motion Web site. Available at: http://www. metamotion.com/hardware/motion-capture-hardware-gloves-Datagloves.htm. Accessed January 12, 2004.
144. Cybergloves®. Meta Motion Web site. Available at: http://www. metamotion.com/hardware/motion-capture-hardware-gloves-Cybergloves.htm. Accessed January 12, 2004.
145. FastSCAN™ Cobra™: the fast and easy digital scanner. Polhemus Web site. Available at: http://www.polhemus.com/fastscan.htm. Accessed April 21, 2004.
146. Proceedings of the 8th Annual Medicine Meets Virtual Reality Conference; January 27-30, 2000; Newport Beach, Calif.
147. The Hand-Immersive Workstation. Available at: http://www.simcen. org/surgery/hardware/ReachIn_Workstation.htm. Accessed February 20, 2004.
148. IREX (Interactive Rehabilitation & Exercise System). Available at: http://www.irexonline.com. Accessed April 20, 2004.
149. Whitney SL, Sparto PJ, Brown KE, et al. The potential use of virtual reality in vestibular rehabilitation: preliminary findings with the BNAVE. Neurol Report. 2002;26:72-78.
150. Hoffman HG, Patterson DR, Carrougher GJ. Use of virtual reality for adjunctive treatment of adult burn pain during physical therapy: a controlled study. Clin J Pain. 2000;16:244-250.
151. Human Interface Technology Lab Web site. Available at: http://www.hitl.washington.edu/projects/burn. Accessed April 13, 2004.
152. Pizzamiglio L, Fasotti L, Jehkonen M, et al. The use of optokinetic stimulation in rehabilitation of the hemineglect disorder. Cortex. 2004;40:441-450.
153. Zeloni G, Farne A, Baccini M. Viewing less to see better. J Neurol Neurosurg Psychol. 2002;73:195-198.
154. Pierce SR, Buxbaum LJ. Treatments of unilateral neglect: a review. Arch Phys Med Rehabil. 2002;83:256-268.
155. Parton A, Malhotra P, Husain M. Hemispatial neglect. J Neurol Neurosurg Psychol. 2004;75:13-21.
156. Weiss PL, Naveh Y, Katz N. Design and testing of a virtual environment to train CVA patients with unilateral spatial neglect to cross a street safely. Occup Ther Int. 2003;10:39-55.
157. Boian RF, Burdea GC, Deutsch JE, Winter SH. Street crossing using a virtual environment simulator. To appear in the Proceedings of IWVR 2004, Lausanne, Switzerland. Arailable at: http://www.caip.rutgers.edu/vrlab/ publications/papers/2004_iwvr_boian.pdf. Accessed May 14, 2004.
158. Guide to Physical Therapist Practice. 2nd ed rev. Alexandria, Va: American Physical Therapy Association; 2003.